Evaluation of thymoquinone cancer chemo-preventive effect on oral leukoplakia: a randomized clinical trial
Exploration of Medicine · 03.03.2025
DOI: 10.37349/emed.2025.1001290 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Exploration of Medicine, online erschienen am 03.03.2025. Verfasst von Ghada Nabil und 5 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben.
Abstract (Originalsprache)
Aim
This randomized clinical trial aimed to investigate the chemo-preventive role of thymoquinone in Nigella sativa extract in managing oral leukoplakia clinically, histologically, and at the molecular level.
Methods
A total of 48 patients with oral leukoplakia were randomly allocated to three groups; Group A received local muco-adhesive tablets with Nigella sativa extract in 10 mg/kg dose, for three months, Group B same intervention but with Nigella sativa extract in 5 mg/kg dose, and lastly Group C was the placebo group. The outcomes assessed were clinical improvement, histologic improvement (degree of dysplasia), and molecular biomarkers Ki-67 and caspase-3 by immunohistochemistry.
Results
There was a statistically significant decrease in lesion size in Groups A and B compared to the placebo group. At the molecular level, there was a statistically significant decrease in the expression of Ki-67 in both the Nigella sativa groups compared to the placebo group. While there was a statistically significant increase in caspase-3 in Group A only compared to the other groups.
Conclusions
Thymoquinone in Nigella sativa extract is a promising chemo-preventive agent that can be used in the management of oral leukoplakia (the trial is registered on clinicaltrials.gov identifier: NCT03208790).
Zitieren
APA
Nabil, G., Zahran, F. M., ElMeshad, A., Fawzy, A., Ghalwash, D., & Elsaadany, B. (2025). Evaluation of thymoquinone cancer chemo-preventive effect on oral leukoplakia: a randomized clinical trial. Exploration of Medicine. https://doi.org/10.37349/emed.2025.1001290
Vancouver
Nabil G, Zahran FM, ElMeshad A, Fawzy A, Ghalwash D, Elsaadany B. Evaluation of thymoquinone cancer chemo-preventive effect on oral leukoplakia: a randomized clinical trial. Exploration of Medicine. 2025. doi:10.37349/emed.2025.1001290
BibTeX
@article{Nabil2025,
author = {Nabil, Ghada and Zahran, Fat’heya M. and ElMeshad, Aliaa and Fawzy, Ahmed and Ghalwash, Dalia and Elsaadany, Basma},
title = {Evaluation of thymoquinone cancer chemo-preventive effect on oral leukoplakia: a randomized clinical trial},
journal = {Exploration of Medicine},
year = {2025},
doi = {10.37349/emed.2025.1001290}
}
EUVIMED